Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Tiansheng Pharmaceutical Group Co., Ltd.

Market Cap 1.57B 232M 202M 187M 175M 328M 21.85B 330M 2.22B 860M 10.76B 869M 851M 37.35B P/E 2024
-16.5x
P/E 2025 -27.9x
Enterprise Value 1.65B 243M 212M 196M 184M 345M 22.96B 347M 2.33B 903M 11.3B 913M 894M 39.23B EV / Sales 2024
2.7x
EV / Sales 2025 3.16x
Free-Float
53.4%
Yield 2024 *
-
Yield 2025 -
05-08 Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement MT
04-28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-12 Three Tiansheng Pharma Drugs Set to Win Bids for China's Drug Procurement Program MT
11-07 Tiansheng pharmaceutical and its controlling shareholder penalised, fined RE
29/10/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
14/10/25 Tiansheng Pharmaceutical Group Subsidiaries Tentatively Win Bulk Drug Tenders in Guangdong MT
15/09/25 Tiansheng Pharmaceutical Gets China Supplementary Drug Approval for Sodium Bicarbonate Injection MT
27/08/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
28/04/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
28/04/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
10/02/25 Tiansheng Pharmaceutical Passes Consistency Evaluation for Antibiotic MT
25/12/24 Chongqing Pharmaceutical Group Changsheng Pharmaceutical Co., Ltd announced that it expects to receive CNY 60 million in funding from C.Q. Pharmaceutical Holding Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd. CI
1 day-1.99%
1 week-4.09%
Current month-8.70%
1 month-5.92%
3 months-4.64%
6 months+1.23%
Current year+1.44%
1 week 4.92
Extreme 4.92
5.22
1 month 4.92
Extreme 4.92
5.59
Current year 4.81
Extreme 4.81
5.65
1 year 4.52
Extreme 4.52
5.81
3 years 3.17
Extreme 3.17
5.97
5 years 3.17
Extreme 3.17
5.99
10 years 3.17
Extreme 3.17
35.18
Manager TitleAgeSince
Chief Executive Officer 33 05/12/2018
Director of Finance/CFO 52 22/12/2013
Corporate Officer/Principal 54 10/12/2020
Director TitleAgeSince
Chairman 33 05/12/2018
Director/Board Member 54 10/12/2020
Director/Board Member 66 10/12/2020
Date Insider Type Main position Quantity % Market Cap.
24/07/23Sell

Chief Financial Officer

43,100 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
-1.99%-4.09%+9.07%-2.38% 232M
-1.21%-3.04%+44.03%+142.51% 980B
-2.48%-5.18%+52.47%+39.36% 550B
-2.14%-4.94%+16.83%+58.18% 382B
+0.25%-3.09%+23.33%+16.78% 316B
+0.61%-1.69%+27.35%+14.22% 272B
+0.22%-3.10%+24.67%+30.69% 268B
+4.59%+1.98%-38.43%-46.41% 199B
-1.19%-4.95%+16.68%+48.70% 182B
-1.35%-1.46%+14.06%+59.46% 154B
Average -0.47%-3.12%+19.01%+36.11% 330.26B
Weighted average by Cap. -0.78%-3.68%+29.49%+63.49%

Financials

2024 2025
Net sales 570M 84.17M 73.39M 67.97M 63.63M 119M 7.94B 120M 806M 312M 3.91B 316M 309M 13.57B 514M 75.95M 66.22M 61.33M 57.41M 108M 7.17B 108M 728M 282M 3.53B 285M 279M 12.25B
Net income -87.4M -12.91M -11.26M -10.43M -9.76M -18.31M -1.22B -18.42M -124M -47.94M -600M -48.47M -47.43M -2.08B -55.42M -8.19M -7.14M -6.61M -6.19M -11.61M -773M -11.68M -78.44M -30.4M -380M -30.74M -30.08M -1.32B
Net Debt 97.19M 14.36M 12.52M 11.59M 10.85M 20.36M 1.35B 20.48M 138M 53.31M 667M 53.9M 52.74M 2.32B 78.93M 11.66M 10.17M 9.42M 8.81M 16.53M 1.1B 16.63M 112M 43.29M 542M 43.77M 42.83M 1.88B
Logo Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co Ltd is a China-based company primarily engaged in drug R&D, production, sales, and the cultivation and processing of traditional Chinese medicinal materials. The Company's products include tablets, capsules, granules, teas, pills, and injections. Product varieties cover pediatrics, gynecology, cardiovascular system, digestive system, orthopedics, respiratory medicine, and anti-infective treatment areas. The Company's products are mainly sold to the domestic market.
Employees
1,273
Date Price Change Volume
18/06/26 4.930 ¥ -1.99% 2,501,050
17/06/26 5.030 ¥ -1.95% 2,961,450
16/06/26 5.130 ¥ -0.97% 3,257,250
15/06/26 5.180 ¥ +0.78% 2,949,100
  1. Stock Market
  2. Stocks
  3. 002872 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!